Clinical Trial Update: Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effectiveness and safety of Lipovirtide combined with nucleoside drugs in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lipovirtide
• Nucleoside drugs (nucleoside reverse transcriptase inhibitors)

Snippet

Sponsor: Shanxi Kangbao Biological Product Co., Ltd. | Conditions: HIV | Phase 2 | Status: COMPLETED